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The autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is associated 
with structural retinal abnormalities either directly visible on funduscopy or revealed by 
optical coherence tomography (OCT). Most patients with ARSACS have a whitish peri-
papillary appearance corresponding to a thickening of the peripapillary retinal nerve fiber 
layer. OCT has also shown an absence of the physiological foveal depression. Abnormal 
electroretinography (ERG) has previously been reported in only two cases, without 
further details. This report describes a patient with ARSACS in whom careful full-field 
ERG revealed dysfunction of the retinal On− bipolar cells with sparing of photoreceptor 
function. This is the first report of inner retinal dysfunction in ARSACS.
Keywords: autosomal recessive spastic ataxia of Charlevoix-saguenay, Charlevoix-saguenay, erg, on− bipolar 
cells, electronegative electroretinography, foveal hypoplasia, peripapillary retinal nerve fiber layer thickening, 
optical coherence tomography
INtRoDUCtIoN
The autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), related to mutation in 
the SACS gene on chromosome 13 (1), is mainly characterized by progressive ataxia of childhood 
onset and limb spasticity. The first description of ARSACS also reported the presence of “retinal 
striations” (2). Thickening of the peripapillary retinal nerve fiber layer (RNFL) is visible on fundus 
examination and appears pathognomonic of ARSACS; it has not been reported in other forms of 
hereditary ataxia (3). However, there is phenotypic variability as not all patients with ARSACS 
exhibit peripapillary RNFL thickening (4, 5). Although two cases have been described as having 
asymptomatic retinal dysfunction on electroretinography [ERG (2, 6)], visual performance has 
otherwise been reported to be normal (2, 7).
This report presents the results of detailed retinal imaging, ERG, and brain imaging in a patient 
with genetically confirmed ARSACS.
Case RepoRt
A 21-year-old man was referred for investigation of progressive visual loss in the setting of slow 
progressive ataxia since age 2. Neurological examination revealed a slight dysarthric speech, a mod-
erate spastic paraparesis with brisk osteotendinous reflexes, a moderate dysmetria in four limbs, 
and a spastic and ataxic gait without sensory disturbance. Genetic testing for Friedreich ataxia and 
spinocerebellar ataxia type 1, 2, 3, 6, 7, and 17 were negative. Serum vitamin E level was normal. 
A diagnosis of spinocerebellar ataxia of unknown etiology was given.
Distance visual acuity was 4/10 in either eye whereas near vision was better at 6/10 RE and 
8/10 LE. Color vision was normal on Ishihara pseudoisochromatic plates, and computerized 
FIGURe 2 | Optical coherence tomography (OCT). Top—OCT (Cirrus, Carl Zeiss Meditec, Inc., Germany). Peripapillary retinal nerve fiber layer (RNFL) was regularly 
thickened in both eyes (190 µm RE, 198 µm LE; norm 85–110 µm), in all clock hours, with the preservation of the “double hump” appearance (i.e., thicker RNFL 
superiorly and inferiorly). Bottom—OCT (Spectralis, Heidelberg Engineering GmbH, Germany). A high definition horizontal line through the fovea shows the absence 
of the normal physiological foveal depression in both eyes (arrow), despite the outer retinal ellipsoid layer exhibiting normal thickening at the fovea (arrowhead).
FIGURe 1 | Fundus photographs. Top—fundus examination reveals a  
whitish striated appearance of the peripapillary retina. Note that the disk 
margin is clear, without dilation of the optic disk capillaries or hemorrhages, 
and that the retinal abnormality begins distant from the optic disk margin. 
Bottom—red free photographs show better the appearance of the 
peripapillary retinal nerve fiber layer.
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static visual fields were full bilaterally. Central keratoconus 
was responsible for the decreased visual acuity.
Fundus examination revealed a striated whitish peri-
papillary appearance with a normal optic disk in both eyes 
(Figure 1). A significant thickening of the peripapillary RNFL 
was demonstrated by optical coherence tomography (OCT). 
Macular OCT showed absence of the normal foveal depres-
sion in both eyes (Figure  2). Fluorescein and indocyanine 
green retinal angiography were normal. Full-field ERG was 
performed to incorporate ISCEV standards (8). Bright flash 
dark-adapted ERG had an electronegative waveform (i.e., 
the b-wave amplitude was lower than the a-wave amplitude), 
in keeping with inner retinal rod system dysfunction (Figure 3). 
Photopic 30  Hz flicker ERG was mildly delayed bilaterally, 
and there was reduction in the b:a ratio of the On− response 
when On−/Off− response recording was performed.
Magnetic resonance imaging revealed atrophy of the cer-
ebellar vermis (Figure  4) and symmetrical linear hypointense 
striations on either side of the pontine midline on T1-weighted 
sequences (Figure  4). The combination of an atrophy of the 
superior cerebellar vermis with the presence of linear hypoin-
tense striated lesions in the pons on T2 or Flair sequences has 
been reported by several authors in ARSACS patients (9, 10). 
Our patient also exhibited mild generalized cerebral atrophy 
with slight dilation of the posterior ventricules and thinning of 
the corpus callosum. Genetic studies showed the presence of a 
homozygous point deletion (c6078) in the SACS gene confirm-
ing the diagnosis of ARSACS.
CoMMeNt
This report provides a comprehensive description of retinal 
structure and function in a patient with mutationally confirmed 
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FIGURe 3 | Electrophysiology. Full-field electroretinography (ERG) was performed using gold foil electrodes. The labeling is conventional and reflects the adaptive 
state of the eye [dark-adapted (DA) and light-adapted (LA)] and the flash strength (in cd·s/m2). The data from a representative normal subject are shown in the lower 
row for comparison. Dim flash DA ERGs (DA 0.01) show no definite abnormality; the bright flash DA ERGs (DA 10.0) have a negative (electronegative) waveform with 
a normal a-wave, confirming normal photoreceptor function, but a lower amplitude b-wave in keeping with inner retinal dysfunction. The 30 Hz flicker ERG is 
bilaterally delayed, and although the single flash LA ERG (LA 3.0) shows no definite abnormality, photopic long duration stimulation, to separate the function of the 
cone On− and Off− pathways, shows a markedly negative On− response (reduced b:a ratio). The findings overall indicate generalized inner retinal dysfunction in 
both rod and cone systems, probably predominantly involving the On− pathways. The pattern electroretinogram (PERG) is bilaterally subnormal in keeping with the 
optical degradation introduced by keratoconus.
FIGURe 4 | Magnetic resonance imaging (3 T). Left—sagittal cut, T1-
weighted sequence revealing cerebellar vermis atrophy (arrow). Right—axial 
cut, T2-weighted sequence revealing bilateral and symmetrical hypointense 
linear lesions in the pons (small arrows in insert).
ARSACS syndrome. Results of MRI were also suggestive of 
ARSACS.
The patient was initially referred for investigation of visual 
acuity reduction, which was actually due to undiagnosed bilateral 
keratoconus. Interestingly, the genes for ARSACS and keratoco-
nus are both on chromosome 13, but genetic studies failed to 
disclose an abnormality at the location of the keratoconus gene.
The first report of ARSACS described “striking and mark-
edly increased visibility of the retinal nerve fibers, mainly in 
the papillomacular bundle area” (2). The exact nature of the 
peripapillary RNFL thickening has been debated, but OCT 
findings suggest hypertrophy of the RNFL rather than myelina-
tion of RNFL (11, 12). The specificity of the peripapillary RNFL 
thickening is 100%, but sensitivity is lower with some patients, 
particularly those of Japanese origin, being reported not to 
exhibit such peripapillary RNFL thickening, either by fundus or 
by OCT examination (4, 5). OCT examination has also recently 
revealed an absence of the physiological foveal depression 
(7, 11–13). However, despite these structural abnormalities, 
visual dysfunction in ARSACS (using standard tests of visual 
acuity, visual field, and color vision) has not been previously 
reported. The present patient had visual acuity loss due to 
previously undiagnosed keratoconus, seemingly unrelated to 
ARSACS.
Electroretinographic investigation of ARSACS patients 
has been reported in only a few patients. Interestingly, one of 
six patients from the original publication and another single 
case exhibited full-field ERG abnormalities, but both were 
incidental findings in the absence of visual complaints (2, 6). 
Neither precise description nor the ERG waveforms were 
published. Results of OCT in patients with ARSACS have never 
demonstrated abnormalities or thinning of the outer retina. 
The present patient showed inner retinal dysfunction in both 
rod and cone systems, probably confined to the On− bipolar 
cells (Off− responses were normal). There are many causes of 
a “negative ERG” waveform, such as X-linked retinoschisis and 
forms of congenital stationary night blindness [e.g., Ref. (14)], 
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but those disorders are usually symptomatic, whereas in this 
patient his only visual symptoms related to the keratoconus.
More than 100 mutations reported to date in ARSACS result 
in a decreased production of sacsin, a chaperone protein (15). 
Pathological studies in humans have revealed swelling both of 
thalamic and cerebellar neurons and, in a knockout mouse 
model of ARSACS, altered mitochondrial transport, slowing of 
axoplasmic flow within long axons, and an abnormal cerebel-
lar dendritic network have been demonstrated (5, 15). Retinal 
examination reveals structural changes in the retina in most 
patients, particularly peripapillary RNFL thickening. Recently, it 
has been hypothesized that peripapillary RNFL thickening might 
result from the slowing of axoplasmic flow within retinal gan-
glion cells axons and that ARSACS may be a storage disorder (5). 
Accumulation of proteins at an inner retinal level, or a secondary 
effect on retinal bipolar cells, could explain the electroretino-
graphic abnormalities described herein.
The electroretinographic data in this patient show that 
ARSACS can manifest inner retinal dysfunction in both rod 
and cone systems. Full-field ERG in a greater number of 
ARSACS patients would help determine the incidence of this 
dysfunction and further elucidate the nature and significance 
of the findings.
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